Pharmaceuticals: Beating the Hell Out of the Average

Pharmaceuticals: Beating the Hell Out of the Average
Bichler, Shimshon and Nitzan, Jonathan. (2021). Research Note. June. pp. 1-5. (Article - Working Paper; English).

Full Text Available As:

Preview	Cover Image 20210600_bn_pharmaceuticals_beating_the_hell_out_of_the_average_rn_front.jpg Download (25kB) | Preview
Preview	PDF (Full Text) 20210600_bn_pharmaceuticals_beating_the_hell_out_of_the_average_rn.pdf Download (491kB) | Preview
	HTML (Full Text) 20210600_bn_pharmaceuticals_beating_the_hell_out_of_the_average_rn_web.htm Download (22kB)
	Other (Excel data for the figure) 20210600_bn_pharmaceuticals_beating_the_hell_out_of_the_average_rn_data.xlsx Download (55kB)
Preview	Other (Figure 1) fig01.JPG Download (231kB) | Preview
Preview	Other (Figure 2) fig02.JPG Download (216kB) | Preview

Alternative Locations

https://www.econstor.eu/handle/10419/234557, https://www.academia.edu/49173148/Pharmaceuticals_Beating_the_Hell_Out_of_the_Average

Abstract or Brief Description

A lot has been written on the imminent decline of pharmaceuticals: their falling production, reduced R&D, declining innovation, the opioid crisis, patent cliffs, biting competition from generic drugs, growing opposition to IPR. The list goes on. Judging by the yardsticks that matter the most, though – namely, the companies’ relative profit and relative capitalization – pharmaceuticals are doing just fine. In fact, based on these yardsticks, they remain the most powerful corporate sector of all.

Language

English

Publication Type

Article - Working Paper

Keywords

capitalization finance pharmaceutical power profit

Subject

BN International & Global
BN Money & Finance
BN Power
BN Science & Technology
BN Value & Price
BN Business Enterprise
BN Capital & Accumulation
BN Distribution

Depositing User

Jonathan Nitzan

Date Deposited

08 Jun 2021 17:02

Last Modified

09 Jun 2021 16:45

URL:

http://bnarchives.yorku.ca/id/eprint/693

Actions (login required)

View Item